Clinical Trial Update: Erythropoietin in Traumatic Brain Injury (EPO-TBI) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating erythropoietin for traumatic brain injury has completed enrollment. Results are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Australian and New Zealand Intensive Care Research Centre | Conditions: Traumatic Brain Injury | Phase 3 | Status: COMPLETED